Defining the molecular pathways of Alzheimer's disease raises new possibilities for treatment (pages 864–875).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Potential applications of magnetic particles to detect and treat Alzheimer's disease
Nanoscale Research Letters Open Access 01 October 2014
-
RIG-1 receptor expression in the pathology of Alzheimer’s disease
Journal of Neuroinflammation Open Access 02 April 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754–760 (1995).
Levy-Lahad, E. et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973–977 (1995).
Scheuner, D. et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864–870 (1996).
Jarrett, J.T. & Lansbury, P.T. Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? Cell 73, 1055–1058 (1993).
Goate, A. et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704–706 (1991).
Suzuki, N. et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264, 1336–1340 (1994).
Citron, M. et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360, 672–674 (1992).
Cai, X.-D., Golde, T.E. & Younkin, G.S. Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259, 514–516 (1993).
Martins, R.N. et al. High levels of amyloid-β protein from S182 (Glu246) familial Alzheimer's cells. Neuroreport 7, 217–220 (1995).
Yankner, B.A., Duffy, L.K. & Kirschner, D.A. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250, 279–282 (1990).
Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G. & Cotman, C.W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13, 1676–1687 (1993).
Lorenzo, A. & Yankner, B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. USA 91, 12243–12247 (1994).
Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373, 523–527 (1995).
Mattson, M.P. et al. Evidence for excitoprotective and interneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10, 243–254 (1993).
Yamatsuji, T. et al. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science 272, 1349–1352 (1996).
Alonso, A., Grundke-Iqbal, I. & Iqbal, K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nature Med. 2, 783–787 (1996).
Wang, J.-Z., Grundke-Iqbal, I. & Iqbal, K. Glyco-sylation of microtubule-associated protein tau: An abnormal posttranslational modification in Alzheimer's disease. Nature Med. 2, 871–875 (1996).
Biernat, J., Gustke, N., Drewes, G., Mandelkow, E.-M. & Mandelkow, E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11, 153–163 (1993).
Bramblett, G.T. et al. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10, 1089–1099 (1993).
Busciglio, J., Lorenzo, A., Yeh, J. & Yankner, B.A. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879–888 (1995).
Schweers, O., Mandelkow, E.-M., Biernat, J. & Mandelkow, E. Oxidation of cysteine-322 in the repeat domain of microtubule-associated protein tau controls the in vitro assembly of paired helical filaments. Proc. Natl. Acad. Sci. USA 92, 8463–8467 (1995).
Strittmatter, W.J. et al. Apolipoprotein E: High avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977–1981 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yanker, B. New clues to Alzheimer's disease: Unraveling the roles of amyloid and tau. Nat Med 2, 850–852 (1996). https://doi.org/10.1038/nm0896-850
Issue Date:
DOI: https://doi.org/10.1038/nm0896-850
This article is cited by
-
Selenium and Zinc against Aβ25–35-Induced Cytotoxicity and Tau Phosphorylation in PC12 Cells and Inhibits γ-cleavage of APP
Biological Trace Element Research (2018)
-
Potential applications of magnetic particles to detect and treat Alzheimer's disease
Nanoscale Research Letters (2014)
-
RIG-1 receptor expression in the pathology of Alzheimer’s disease
Journal of Neuroinflammation (2014)
-
The Pathogenic Implication of Abnormal Interaction Between Apolipoprotein E Isoforms, Amyloid-beta Peptides, and Sulfatides in Alzheimer’s Disease
Molecular Neurobiology (2010)
-
Nicotine and inflammatory neurological disorders
Acta Pharmacologica Sinica (2009)